0
Obstructive Lung Diseases |

Risk Factor Stratification for COPD Exacerbation in an Outpatient Population Resulting in Acute Healthcare Resource Utilization

Furqan Shoaib Siddiqi*, MD; Rachael Hauser, MD; Peg Bicker, MD; Jennifer Jackson, MD
Author and Funding Information

University of Kansas School of Medicine Wichita, Wichita, KS


Chest. 2012;142(4_MeetingAbstracts):683A. doi:10.1378/chest.1389192
Text Size: A A A
Published online

Abstract

SESSION TYPE: New Insights into COPD

PRESENTED ON: Monday, October 22, 2012 at 04:00 PM - 05:30 PM

PURPOSE: COPD is the fourth leading cause of death in the United States. The average cost of COPD exacerbation ranges from $7242 to $44,904 depending on severity. Primary care physicians can play critical roles in controlling the risk factors for COPD exacerbation in the outpatient population and reduce the economic burden on healthcare.

METHODS: A total of 89 patients (47% of eligible patients) between the ages 18 and 75 with an established diagnosis of COPD were selected from the clinic registry. Patient interviews and chart reviews were done to determine age, gender, GOLD staging, current management, smoking status, and pulmonary rehabilitation in last 2 years. The primary outcome was healthcare resource utilization for COPD exacerbation in the past 6 months, including hospitalizations, ER visits, acute office visits, and calls to the physician office for antibiotics. Regression analysis was calculated to determine the association of risk factors with the primary outcomes. The study was powered at 80%.

RESULTS: A total of 62% of patients were males and 41% had GOLD stage 2 COPD. Multivariate analysis showed that patients who were not on appropriate treatment were more likely to have utilized healthcare resources in the past 6 months (P<0.005). GOLD Stage, smoking status, age, and gender did not show a statistically significant association with utilization of healthcare resources. Only 8% of patients were referred for pulmonary rehabilitation.

CONCLUSIONS: Being on appropriate treatment is the single most important factor that determines the risk of acute exacerbations of COPD. Despite its well documented benefits in COPD patients, pulmonary rehabilitation was extremely underutilized by primary care physicians.

CLINICAL IMPLICATIONS: Primary care physicians can play a significant role in reducing the healthcare financial burden by using appropriate treatment for COPD as outlined by the ACP/ACCP/ATS/ERS guidelines. Pulmonary rehabilitation, if utilized, has proven effects in improving symptoms.

DISCLOSURE: The following authors have nothing to disclose: Furqan Shoaib Siddiqi, Rachael Hauser, Peg Bicker, Jennifer Jackson

No Product/Research Disclosure Information

University of Kansas School of Medicine Wichita, Wichita, KS

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543